BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu T, Wu Y, Chen W, Hung Y, Yu Q. Targeting Oxidative Stress and Endothelial Dysfunction Using Tanshinone IIA for the Treatment of Tissue Inflammation and Fibrosis. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/2811789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Shao M, Yao J, Yang S, Cheng W, Ma L, Li W, Cao J, Zhang Y, Hu Y, Li C, Wang Y, Wang W. Neocryptotanshinone protects against myocardial ischemia-reperfusion injury by promoting autolysosome degradation of protein aggregates via the ERK1/2-Nrf2-LAMP2 pathway. Phytomedicine 2023;110:154625. [PMID: 36586206 DOI: 10.1016/j.phymed.2022.154625] [Reference Citation Analysis]
2 Li X, Yang Y, Song Y, Nie F, Fu C, Qin Y. Effect of Shuangdan Mingmu Capsule on Diabetic Retinopathy in Rats via Regulation of miRNAs. Diabetes Metab Syndr Obes 2022;15:3181-94. [PMID: 36268199 DOI: 10.2147/DMSO.S379611] [Reference Citation Analysis]
3 Lu L, Xiong Y, Zhou J, Wang G, Mi B, Liu G, Cao J. The Therapeutic Roles of Cinnamaldehyde against Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-23. [DOI: 10.1155/2022/9177108] [Reference Citation Analysis]
4 Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, Kong L, Xu Q, Ma H, Sun Y. New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]